We identified rare coding variants associated with Alzheimer's disease in a three-stage case-control study of 85,133 subjects. In stage 1, we genotyped 34,174 samples using a whole-exome microarray. In stage 2, we tested associated variants (P < 1 × 10-4) in 35,962 independent samples using de novo genotyping and imputed genotypes. In stage 3, we used an additional 14,997 samples to test the most significant stage 2 associations (P < 5 × 10-8) using imputed genotypes. We observed three new genome-wide significant nonsynonymous variants associated with Alzheimer's disease: a protective variant in PLCG2 (rs72824905: p.Pro522Arg, P = 5.38 × 10-10, odds ratio (OR) = 0.68, minor allele frequency (MAF)cases = 0.0059, MAFcontrols = 0.0093), a risk variant in ABI3 (rs616338: p.Ser209Phe, P = 4.56 × 10-10, OR = 1.43, MAFcases = 0.011, MAFcontrols = 0.008), and a new genome-wide significant variant in TREM2 (rs143332484: p.Arg62His, P = 1.55 × 10-14, OR = 1.67, MAFcases = 0.0143, MAFcontrols = 0.0089), a known susceptibility gene for Alzheimer's disease. These protein-altering changes are in genes highly expressed in microglia and highlight an immune-related protein-protein interaction network enriched for previously identified risk genes in Alzheimer's disease. These genetic findings provide additional evidence that the microglia-mediated innate immune response contributes directly to the development of Alzheimer's disease.

Sims, R., Van Der Lee, S.j., Naj, A.c., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., et al. (2017). Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. NATURE GENETICS, 49(9), 1373-1384 [10.1038/ng.3916].

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

Mukherjee S.;CECCHETTI, ROSALBA;Caltagirone C.;Li G.;Gallo M.;
2017

Abstract

We identified rare coding variants associated with Alzheimer's disease in a three-stage case-control study of 85,133 subjects. In stage 1, we genotyped 34,174 samples using a whole-exome microarray. In stage 2, we tested associated variants (P < 1 × 10-4) in 35,962 independent samples using de novo genotyping and imputed genotypes. In stage 3, we used an additional 14,997 samples to test the most significant stage 2 associations (P < 5 × 10-8) using imputed genotypes. We observed three new genome-wide significant nonsynonymous variants associated with Alzheimer's disease: a protective variant in PLCG2 (rs72824905: p.Pro522Arg, P = 5.38 × 10-10, odds ratio (OR) = 0.68, minor allele frequency (MAF)cases = 0.0059, MAFcontrols = 0.0093), a risk variant in ABI3 (rs616338: p.Ser209Phe, P = 4.56 × 10-10, OR = 1.43, MAFcases = 0.011, MAFcontrols = 0.008), and a new genome-wide significant variant in TREM2 (rs143332484: p.Arg62His, P = 1.55 × 10-14, OR = 1.67, MAFcases = 0.0143, MAFcontrols = 0.0089), a known susceptibility gene for Alzheimer's disease. These protein-altering changes are in genes highly expressed in microglia and highlight an immune-related protein-protein interaction network enriched for previously identified risk genes in Alzheimer's disease. These genetic findings provide additional evidence that the microglia-mediated innate immune response contributes directly to the development of Alzheimer's disease.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/26 - Neurologia
English
Con Impact Factor ISI
Adaptor Proteins, Signal Transducing; Alzheimer Disease; Amino Acid Sequence; Case-Control Studies; Exome; Gene Expression Profiling; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Immunity, Innate; Linkage Disequilibrium; Membrane Glycoproteins; Microglia; Odds Ratio; Phospholipase C gamma; Protein Interaction Maps; Receptors, Immunologic; Sequence Homology, Amino Acid; Polymorphism, Single Nucleotide
Sims, R., Van Der Lee, S.j., Naj, A.c., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., et al. (2017). Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. NATURE GENETICS, 49(9), 1373-1384 [10.1038/ng.3916].
Sims, R; Van Der Lee, Sj; Naj, Ac; Bellenguez, C; Badarinarayan, N; Jakobsdottir, J; Kunkle, Bw; Boland, A; Raybould, R; Bis, Jc; Martin, Er; Grenier-Boley, B; Heilmann-Heimbach, S; Chouraki, V; Kuzma, Ab; Sleegers, K; Vronskaya, M; Ruiz, A; Graham, Rr; Olaso, R; Hoffmann, P; Grove, Ml; Vardarajan, Bn; Hiltunen, M; Nothen, Mm; White, Cc; Hamilton-Nelson, Kl; Epelbaum, J; Maier, W; Choi, S-H; Beecham, Gw; Dulary, C; Herms, S; Smith, Av; Funk, Cc; Derbois, C; Forstner, Aj; Ahmad, S; Li, H; Bacq, D; Harold, D; Satizabal, Cl; Valladares, O; Squassina, A; Thomas, R; Brody, Ja; Qu, L; Sanchez-Juan, P; Morgan, T; Wolters, Fj; Zhao, Y; Garcia, Fs; Denning, N; Fornage, M; Malamon, J; Naranjo, Mcd; Majounie, E; Mosley, Th; Dombroski, B; Wallon, D; Lupton, Mk; Dupuis, J; Whitehead, P; Fratiglioni, L; Medway, C; Jian, X; Mukherjee, S; Keller, L; Brown, K; Lin, H; Cantwell, Lb; Panza, F; Mcguinness, B; Moreno-Grau, S; Burgess, Jd; Solfrizzi, V; Proitsi, P; Adams, Hh; Allen, M; Seripa, D; Pastor, P; Cupples, La; Price, Nd; Hannequin, D; Frank-Garcia, A; Levy, D; Chakrabarty, P; Caffarra, P; Giegling, I; Beiser, As; Giedraitis, V; Hampel, H; Garcia, Me; Wang, X; Lannfelt, L; Mecocci, P; Eiriksdottir, G; Crane, Pk; Pasquier, F; Boccardi, V; Henandez, I; Barber, Rc; Scherer, M; Tarraga, L; Adams, Pm; Leber, M; Chen, Y; Albert, Ms; Riedel-Heller, S; Emilsson, V; Beekly, D; Braae, A; Schmidt, R; Blacker, D; Masullo, C; Schmidt, H; Doody, Rs; Spalletta, G; Jr, Wtl; Fairchild, Tj; Bossu, P; Lopez, Ol; Frosch, Mp; Sacchinelli, E; Ghetti, B; Yang, Q; Huebinger, Rm; Jessen, F; Li, S; Kamboh, Mi; Morris, J; Sotolongo-Grau, O; Katz, Mj; Corcoran, C; Dunstan, M; Braddel, A; Thomas, C; Meggy, A; Marshall, R; Gerrish, A; Chapman, J; Aguilar, M; Taylor, S; Hill, M; Fairen, Md; Hodges, A; Vellas, B; Soininen, H; Kloszewska, I; Daniilidou, M; Uphill, J; Patel, Y; Hughes, Jt; Lord, J; Turton, J; Hartmann, Am; Cecchetti, R; Fenoglio, C; Serpente, M; Arcaro, M; Caltagirone, C; Orfei, Md; Ciaramella, A; Pichler, S; Mayhaus, M; Gu, W; Lleo, A; Fortea, J; Blesa, R; Barber, Is; Brookes, K; Cupidi, C; Maletta, Rg; Carrell, D; Sorbi, S; Moebus, S; Urbano, M; Pilotto, A; Kornhuber, J; Bosco, P; Todd, S; Craig, D; Johnston, J; Gill, M; Lawlor, B; Lynch, A; Fox, Nc; Hardy, J; Albin, Rl; Apostolova, Lg; Arnold, Se; Asthana, S; Atwood, Cs; Baldwin, Ct; Barnes, Ll; Barral, S; Beach, Tg; Becker, Jt; Bigio, Eh; Bird, Td; Boeve, Bf; Bowen, Jd; Boxer, A; Burke, Jr; Burns, Jm; Buxbaum, Jd; Cairns, Nj; Cao, C; Carlson, Cs; Carlsson, Cm; Carney, Rm; Carrasquillo, Mm; Carroll, Sl; Diaz, Cc; Chui, Hc; Clark, Dg; Cribbs, Dh; Crocco, Ea; Decarli, C; Dick, M; Duara, R; Evans, Da; Faber, Km; Fallon, Kb; Fardo, Dw; Farlow, Mr; Ferris, S; Foroud, Tm; Galasko, Dr; Gearing, M; Geschwind, Dh; Gilbert, Jr; Graff-Radford, Nr; Green, Rc; Growdon, Jh; Hamilton, Rl; Harrell, Le; Honig, Ls; Huentelman, Mj; Hulette, Cm; Hyman, Bt; Jarvik, Gp; Abner, E; Jin, L-W; Jun, G; Karydas, A; Kaye, Ja; Kim, R; Kowall, Nw; Kramer, Jh; Laferla, Fm; Lah, Jj; Leverenz, Jb; Levey, Ai; Li, G; Lieberman, Ap; Lunetta, Kl; Lyketsos, Cg; Marson, Dc; Martiniuk, F; Mash, Dc; Masliah, E; Mccormick, Wc; Mccurry, Sm; Mcdavid, An; Mckee, Ac; Mesulam, M; Miller, Bl; Miller, Ca; Miller, Jw; Morris, Jc; Murrell, Jr; Myers, Aj; O'Bryant, S; Olichney, Jm; Pankratz, Vs; Parisi, Je; Paulson, Hl; Perry, W; Peskind, E; Pierce, A; Poon, Ww; Potter, H; Quinn, Jf; Raj, A; Raskind, M; Reisberg, B; Reitz, C; Ringman, Jm; Roberson, Ed; Rogaeva, E; Rosen, Hj; Rosenberg, Rn; Sager, Ma; Saykin, Aj; Schneider, Ja; Schneider, Ls; Seeley, Ww; Smith, Ag; Sonnen, Ja; Spina, S; Stern, Ra; Swerdlow, Rh; Tanzi, Re; Thornton-Wells, Ta; Trojanowski, Jq; Troncoso, Jc; Van Deerlin, Vm; Van Eldik, Lj; Vinters, Hv; Vonsattel, Jp; Weintraub, S; Welsh-Bohmer, Ka; Wilhelmsen, Kc; Williamson, J; Wingo, Ts; Woltjer, Rl; Wright, Cb; Yu, C-E; Yu, L; Garzia, F; Golamaully, F; Septier, G; Engelborghs, S; Vandenberghe, R; De Deyn, Pp; Fernadez, Cm; Benito, Ya; Thonberg, H; Forsell, C; Lilius, L; Kinhult-Stahlbom, A; Kilander, L; Brundin, R; Concari, L; Helisalmi, S; Koivisto, Am; Haapasalo, A; Dermecourt, V; Fievet, N; Hanon, O; Dufouil, C; Brice, A; Ritchie, K; Dubois, B; Himali, Jj; Keene, Cd; Tschanz, J; Fitzpatrick, Al; Kukull, Wa; Norton, M; Aspelund, T; Larson, Eb; Munger, R; Rotter, Ji; Lipton, Rb; Bullido, Mj; Hofman, A; Montine, Tj; Coto, E; Boerwinkle, E; Petersen, Rc; Alvarez, V; Rivadeneira, F; Reiman, Em; Gallo, M; O'Donnell, Cj; Reisch, Js; Bruni, Ac; Royall, Dr; Dichgans, M; Sano, M; Galimberti, D; St George-Hyslop, P; Scarpini, E; Tsuang, Dw; Mancuso, M; Bonuccelli, U; Winslow, Ar; Daniele, A; Wu, C-K; Peters, O; Nacmias, B; Riemenschneider, M; Heun, R; Brayne, C; Rubinsztein, Dc; Bras, J; Guerreiro, R; Al-Chalabi, A; Shaw, Ce; Collinge, J; Mann, D; Tsolaki, M; Clarimon, J; Sussams, R; Lovestone, S; O'Donovan, Mc; Owen, Mj; Behrens, Tw; Mead, S; Goate, Am; Uitterlinden, Ag; Holmes, C; Cruchaga, C; Ingelsson, M; Bennett, Da; Powell, J; Golde, Te; Graff, C; De Jager, Pl; Morgan, K; Ertekin-Taner, N; Combarros, O; Psaty, Bm; Passmore, P; Younkin, Sg; Berr, C; Gudnason, V; Rujescu, D; Dickson, Dw; Dartigues, J-F; Destefano, Al; Ortega-Cubero, S; Hakonarson, H; Campion, D; Boada, M; Kauwe, Jk; Farrer, La; Van Broeckhoven, C; Ikram, Ma; Jones, L; Haines, Jl; Tzourio, C; Launer, Lj; Escott-Price, V; Mayeux, R; Deleuze, J-F; Amin, N; Holmans, Pa; Pericak-Vance, Ma; Amouyel, P; Van Duijn, Cm; Ramirez, A; Wang, L-S; Lambert, J-C; Seshadri, S; Williams, J; Schellenberg, Gd
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/192084
Citazioni
  • ???jsp.display-item.citation.pmc??? 348
  • Scopus 483
  • ???jsp.display-item.citation.isi??? 469
social impact